A Review: Novel Oral Lipid Based Formulation for Poorly Soluble Drugs
DOI:
https://doi.org/10.37285/ijpsn.2010.3.4.3Abstract
The percentage of new chemical entities synthesised with low aqueous solubility and high therapeutic efficacy is growing, this presents a major challenge for the drug delivery. To over come this challenge, different methods were developed for the improvement of oral bioavailability, but some have major disadvantages. Recently, oral lipid based formulation is developed for the improvement of oral bioavailability. Lipid based formulation may improve oral bioavailability via several mechanisms; enhancement of gastrointestinal solubilisation remains argueably the most important method of absorption enhancement. This review discusses about lipid formulation, classification system (LFCS) based on different types of surfactants, like water-soluble and water-insoluble and different concentrations of the excipients those are generally recognized as safe (GRAS). Various parameters are mentioned for the evaluation of the lipid based formulation, like equilibrium phase behaviour, self dispersion and size dispersions, in vitro dispersion, droplet size and surface charge, in vitro release. In the USA, Japan and other countries, various poorly soluble drugs are commercially available as lipid-based formulations for oral administration.
Downloads
Metrics
Keywords:
Lipid based Formulation, Oral bioavailability, self- dispersion, in vitro release
Downloads
Published
How to Cite
Issue
Section
References
Anderson B.D., Chemical and related factors controlling lipid solubility, Bull. Tech. Gattefosse. 1999; 92: 11–18.
Attwood D., Florence A.T., Surfactant systems: their chemistry, pharmacy and biology, Chapman and Hall, London, 1983.
Cao Y., Marra M., Anderson B.D., Predictive relationships for the effects of triglyceride ester concentration and water uptake on solubility and partitioning of small molecules into lipid vehicles, Journal of Pharmaceutical Science. 2004; 93: 2768–79.
Cole E.T., Cade D., Benameur H., Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration, Advance Drug Delivery Review. 2008; 60: 747–56
Cuine J.F., Charman W.N., Pouton C.W., Edwards G.A., Porter C.J., Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs, Pharmaceutical Research. 2007; 24: 748–57.
Dressman J ,Schamp K., Beltz K., Characterizing Release from Lipid-Based Formulations in: D.J. Hauss (Ed.), Oral lipid-based formulations: enhancing the bioavailability of C.W.Pouton, C.J.H. Porter / Advanced Drug Delivery Reviews. 2008; 60: 254-55.
Gibson L., Lipid-based excipients for oral drug delivery, in: D.J. Hauss (Ed.), Oral lipid-based formulations: enhancing the bioavailability of poorly water soluble drugs. C.W. Pouton, C.J.H. Porter. Advanced Drug Delivery Reviews 60 (2008) 625–637 635, Informa Healthcare, Inc., New York, 2007, 33–61.
Hauss D. J., Lipid-based systems for oral drug delivery: enhancing the bioavailability of poorly soluble drugs. American Pharmaceutical Review. 2002; winter: 18.
Hauss D.J. (Ed.), Oral lipid-based formulations: enhancing the bioavailability of poorly water soluble drugs, Informa Healthcare, Inc., New York, 2007; 1–339.
Jannin V., Musakhanian J., Marchaud D., Techniques for solid and semi-solid formulations in bioavailability enhancement with lipids, Advance Drug Delivery Review. 2008; 60: 734–46.
Kaukonen A.M., Boyd B.J., Porter C.J., Charman W.N., Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations, Pharmaceutical Research. 2004; 245–53.
Naylor L.J., Bakatselou V., Hornedo N.R., Weiner N.D., Dressman J.B., Dissolution of steroids in bile salt solutions is modified by the presence of lecithin, European Journal of Pharmaceutical Biopharmaceutics. 1995; 41: 346–53.
Porter C.J., Charman W.N., In vitro assessment of oral lipid based formulations, Advance Drug Delivery Review. 2001; 50: S127–47.
Porter C.J.H., Kaukonen A.M., Boyd B.J., Edwards G.A., Charman W.N., Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after oral administration as a medium-chain lipid based microemulsion formulation, Pharmaceutical Research. 2004; 21:1405–12.
Pouton C. W., Porter C. J. H., Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies, Advance Drug Delivery Reviews. 2008; 60:625-37.
Pouton C.W., Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system, European Journal of Pharmaceutical Science. 2006; 29: 278–287.
Pouton C.W., Formulation of self-emulsifying drug delivery systems, Advance Drug Delivery Review. 1997; 25: 47–58.
Strickley R.G., Currently marketed oral lipid-based dosage forms: drugs products and excipients, in: D.J. Hauss (Ed.), Oral lipid-based formulations: enhancing the bioavailability of poorly water soluble drugs, Informa Healthcare, Inc., New York, 2007, 1–31.
Wei, L.; Li, J.; Guo, L.; Nei, S. and Pan, W. Preparation and evaluation of SEDDS and SMEDDS containing Carvedilol, Drug development and industrial pharmacy. 2005; 31: 785-94.
